dengue virus live antigen, CYD serotype 1 100000 UNT / dengue virus live antigen, CYD serotype 2 100000 UNT / dengue virus live antigen, CYD serotype 3 100000 UNT / dengue virus live antigen, CYD serotype 4 100000 UNT Injection
- RxCUI
- 2197701
- RxNorm name
- dengue virus live antigen, CYD serotype 1 100000 UNT / dengue virus live antigen, CYD serotype 2 100000 UNT / dengue virus live antigen, CYD serotype 3 100000 UNT / dengue virus live antigen, CYD serotype 4 100000 UNT Injection
- Display name
- dengue virus live antigen, CYD serotype 1 100000 UNT / dengue virus live antigen, CYD serotype 2 100000 UNT / dengue virus live antigen, CYD serotype 3 100000 UNT / dengue virus live antigen, CYD serotype 4 100000 UNT Injection
- Full name
- dengue virus live antigen, CYD serotype 1 100000 UNT / dengue virus live antigen, CYD serotype 2 100000 UNT / dengue virus live antigen, CYD serotype 3 100000 UNT / dengue virus live antigen, CYD serotype 4 100000 UNT Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:51
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125682 | Dengvaxia | Dengue Tetravalent Vaccine, Live | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 280ee057-3488-4d77-b510-8bc733eeca1e | dengue tetravalent vaccine live 0.5 mL Injection [PSN] · dengue virus live antigen, CYD serotype 1 100000 UNT / dengue virus live antigen, CYD serotype 2 100000 UNT / dengue virus live antigen, CYD serotype 3 100000 UNT / dengue virus live antigen, CYD serotype 4 100000 UNT Injection [SCD] · dengue tetravalent vaccine live 0.5 ML Injection [SY] | 3 | 10 | These highlights do not include all the information needed to use DENGVAXIA safely and effectively. See full prescribing information for DENGVAXIA. DENGVAXIA (Dengue Tetravalent Vaccine, Live) Suspension for Subcutaneous Injection Initial U.S. Approval: 2019 | 20260305 |